Recovery of pefloxacin in saliva and feces and its action on oral and fecal floras of healthy volunteers.
Pefloxacin, a new fluoroquinolone, was given to 10 volunteers in single 400-mg oral doses repeated at 12-h intervals during 7 days. Serum, saliva, and feces samples were collected before and at appropriate intervals after the initiation of treatment. Drug concentrations were determined by bioassay. Qualitative and quantitative analyses of the saliva and fecal floras were performed. Mean concentrations in saliva (3.46 micrograms/ml on day 1 and 7.54 micrograms/ml on day 7) were closely related to levels in serum. High concentrations of pefloxacin were found in the feces (645 micrograms/g on day 8). No modification of oral flora was observed. In the fecal flora, members of the family Enterobacteriaceae were eliminated between days 2 and 8. The alterations in streptococci and anaerobic flora were not significant; Bacteroides fragilis was more resistant to pefloxacin after treatment. Clostridium difficile was not detected, and there was no overgrowth by yeasts. No side effects were observed.
D001419:Bacteria / Q000187:drug effects*; D001646:Bile / Q000378:metabolism; D005243:Feces / Q000032:analysis* / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D009061:Mouth Mucosa / Q000382:microbiology*; D009643:Norfloxacin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D015366:Pefloxacin; D012463:Saliva / Q000032:analysis*
D015366:Pefloxacin; D009643:Norfloxacin